Personalizing cancer treatment using genetic test results
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
This study is looking at how genetic testing can help personalize cancer treatment and prevention for patients with different types of cancer, like breast and prostate cancer, so they can better understand their options based on their unique genetic information.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11049165 on NIH RePORTER |
What this research studies
This research investigates how genetic testing results can be effectively integrated into cancer treatment and prevention strategies for patients. It focuses on patients diagnosed with various types of cancer, including breast, ovarian, pancreatic, and advanced prostate cancer, and aims to personalize their treatment based on genetic information. By linking genetic testing data with cancer registry records, the study seeks to understand current practices and improve the management of genetic test results across different cancer types. Patients may be involved in discussions about their genetic test results and how these can influence their treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with breast, ovarian, pancreatic, or advanced prostate cancer who have undergone genetic testing.
Not a fit: Patients with cancer types not covered by the genetic testing guidelines or those who have not undergone genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual genetic profiles.
How similar studies have performed: Previous research has shown promising results in integrating genetic testing into cancer treatment, indicating that this approach could be beneficial.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Kurian, Allison W. — Stanford University
- Study coordinator: Kurian, Allison W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.